Provided by Tiger Trade Technology Pte. Ltd.

Skye Bioscience Inc.

1.70
+0.01721.02%
Volume:35.26K
Turnover:59.79K
Market Cap:7.45M
PE:-0.17
High:1.75
Open:1.69
Low:1.64
Close:1.68
52wk High:39.92
52wk Low:1.64
Shares:4.39M
Float Shares:2.87M
Volume Ratio:0.74
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.2399
EPS(LYR):-11.2801
ROE:-233.87%
ROA:-95.06%
PB:-14.99
PE(LYR):-0.15

Loading ...

Oct 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Dec 24, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report